| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.021 | 0.5 |
| mRNA | JQ-1 | GDSC1000 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | 0.034 | 0.5 |
| mRNA | BRD-K66453893 | CTRPv2 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | -0.019 | 0.5 |
| mRNA | GDC-0449 | GDSC1000 | pan-cancer | AAC | -0.022 | 0.5 |